Rusnano To Pioneer Nanopack Drugs

The Russian Corporation of Nanotechnologies (Rusnano) has unveiled a RUB831mn (US$27mn) project to create nanoparticle drug delivery systems for medicines. The project, which will run from 2010-2015, aims to produce anti-inflammatory drugs, diuretics and statins, with the first series of drugs to be brought to market in either 2011 or 2012. BMI believes the creation of nanomedicines could provide Russia with strong potential to increase its medicine exports to Western markets over the next five years. However, a number of regulatory challenges must first be

To read the full article, please choose one of the following options: